Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models
BioSpace
Mon, 06/24/24 - 11:24 am
NeuroBo Pharmaceuticals
DA-1726
ADA
weight loss
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool
Mon, 06/17/24 - 11:38 am
Structure Therapeutics
weight loss
Novo Nordisk
obesity
GS-1290
GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:48 am
GLP-1 agonists
Novo Nordisk
Eli Lilly
obesity
weight loss
The Ozempic craze is coming for dogs and cats next
Quartz
Fri, 06/14/24 - 11:17 am
animal health
Okava Pharmaceuticals
OKV-119
weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market
BioSpace
Tue, 06/11/24 - 11:27 am
Syntis Bio
obesity
weight loss
SYNT-101
Merck looks for next-generation opportunities in cardiometabolic drugs
Reuters
Tue, 06/11/24 - 11:23 am
Merck
cardiometabolic diseases
weight loss
Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Medical Marketing and Media
Tue, 06/4/24 - 11:48 am
Novo Nordisk
Wegovy
weight loss
obesity
DTC advertising
Structure Therapeutics pill leads to competitive weight loss in obesity study
BioPharma Dive
Mon, 06/3/24 - 10:26 pm
Structure Therapeutics
obesity
weight loss
GSBR-1290
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
weight loss
obesity
drug shortages
Ro
Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters
Wed, 05/29/24 - 11:48 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Mounjaro
Novo blames US health system after criticism over Wegovy price, Bloomberg reports
Reuters
Tue, 05/28/24 - 10:43 am
Novo Nordisk
drug pricing
Ozempic
Wegovy
weight loss
GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData
BioSpace
Mon, 05/20/24 - 06:02 pm
GLP-1 agonist
weight loss
obesity
diabetes
Genetic profile may predict best response to weight-loss drug Wegovy
Reuters
Mon, 05/20/24 - 11:09 am
Novo Nordisk
Wegovy
genetics
obesity
weight loss
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate
BioSpace
Thu, 05/16/24 - 11:40 am
Roche
Genentech
CT-388
Carmot
weight loss
clinical trials
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters
BioSpace
Wed, 05/15/24 - 11:22 am
insulin
GLP-1 agonist
Novo Nordisk
weight loss
Wegovy
Ozempic
diabetes
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
Reuters
Mon, 05/13/24 - 10:17 pm
Novo Nordisk
Wegovy
weight loss
Aardvark raises $85M to target hunger, not appetite, as it contemplates IPO, pharma deals
San Diego Biotech Networks
Thu, 05/9/24 - 07:37 pm
Aardvark Therapeutics
R&D
weight loss
IPOs
funding
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »